Patients can be treated not as passive recipients of a magic shot, but as active participants in their health journey with coaching, tools, and a tailored treatment plan that meets them where they are
However, people with MS who also have obesity or type 2 diabetes may be candidates for GLP-1 therapy, says Alan David Kaye, MD, PhD, a professor and the vice chair of research in the anesthesiology department at LSU Health in Shreveport, Louisiana
Prophylactic valproate suppresses NF-B activation in the trigeminocervical complex (56) as well as, prophylactic atorvastatin suppresses NF-B activation in trigeminal nucleus caudalis (57)
Their predictive nomogram demonstrated excellent discriminative performance, with an area under the curve ranging from 0.95 to 0.98, and may serve as a useful clinical tool to help prevent potentially fatal bleeding complications